A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

CVS plans to appeal the judgment, which comes after a jury ruled that its long-term care pharmacy benefits manager illegally ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

CVS Health’s pharmacy benefit manager, Caremark, has been ordered to pay $95 million for overbilling Medicare Part D drug reimbursements, a federal judge ruled Wednesday — a decision that ...

The Federal Trade Commission said that it is mailing refund checks to 13,000 Medicare Part D beneficiaries who were overcharged for drugs because a CVS Caremark Corp. business understated the ...

In 2016, CVS Caremark and UnitedHealth’s Optum Rx collected more rebate money from Medicare plans on 80-milligram OxyContin than any other strength—28% of Caremark’s rebate total, and 31% ...

CVS Health and its subsidiaries have experienced a turbulent week in the courts. A former Aetna actuary in the Medicare department won a $95 million False Claims Act judgment (PDF) against ...

CVS Caremark and Optum disputed the FTC's allegations. "CVS Caremark is proud of the work we have done to make insulin more affordable for all Americans with diabetes.

CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.